Ribeiro Ramiro 4

What Happened
Ribeiro Ramiro, Chief Medical Officer of EyePoint, exercised a total of 4,875 option shares on 2026-06-30 (2,437 + 2,438 shares) at an exercise price of $8.26 per share (total cost ~$40,268). The filing shows he sold those shares the same day in the open market: 2,437 shares at $15.00 ($36,555) and 2,438 shares at a weighted average reported price of $15.02 ($36,612), for combined gross proceeds of $73,167. The filing also lists derivative entries showing $0 dispositions that reflect conversion/termination of the options upon exercise.

Key Details

• Transaction date: 2026-06-30 (filed 2026-07-02 — timely filing).
• Option exercise: 4,875 shares at $8.26 each (code M). Cost ≈ $40,268.
• Open-market sales: 2,437 shares at $15.00 and 2,438 shares at a weighted avg ~$15.02 (code S). Gross proceeds ≈ $73,167. Reported sale prices ranged $15.00–$15.06 (footnote F1).
• Footnote F2: Options vesting schedule — 25% vested Jan 3, 2026, remainder vesting monthly over the next three years.
• Shares owned after the transactions: not reported in the provided data.
• Codes explained: M = option exercise/conversion, S = sale.

Context
Exercising options and selling the resulting shares the same day is common when insiders cover the exercise cost and tax obligations; here the exercised shares were sold in the open market on the transaction date. This is a routine insider sale rather than a straightforward buy signal; factual details above show the exercise price, sale prices, and proceeds.